Page 2 - Choon Lui News Today : Breaking News, Live Updates & Top Stories | Vimarsana

KUALA LUMPUR (Jan 12): Promising developments on the vaccine front have stirred investor interest in companies that venture into vaccine distribution, in hopes they will be in for bumper profits. However, it is not clear at this juncture just how much or when these companies can cash in, given just the evaluation process alone for a vaccine to be approved for distribution and use in Malaysia will take five phases. The first phase alone — which is the checking of the vaccine dossiers or research documents — typically takes between 90 and 120 days, according to the Ministry of Health (MoH)....

’s partner Generex Biotechnology Corporation has filed for a trademark for its li-Key vaccine and patent for its Ii-Key-SARS-CoV-2 vaccine. In a statement issued on Thursday, Bintai Kinden said the Ii-Key vaccine was designed to be a complete vaccine for the Covid-19. “The technology offers the safest and best route for the rapid development of a Covid-19 vaccine, ” it said. It explained the complete vaccine is designed to regulate the immune system to provide a targeted, neutralising antibody response. Bintai Kinden managing director Ong Choon Lui said Generex’s Covid-19 vaccine was ...

KUALA LUMPUR: Bintai Kinden Corp Bhd’s partner, Generex Biotechnology Corp has filed for a trademark for its li-Key vaccine, to be known as “The Compl...

KUALA LUMPUR (Dec 15): Berjaya Land Bhd (BLand) is buying freehold land in Bentong, Pahang from Tan Sri Vincent Tan and his family for RM38.45 million, or RM10 per square foot, in cash. In a filing with Bursa Malaysia, BLand said its wholly owned subsidiary Berjaya Engineering Construction Sdn Bhd on Dec 14 entered into a sale and purchase agreement with Deru Klasik Sdn Bhd for the land acquisition. Berjaya boss Tan is the controlling shareholder of Deru Klasik with a 75% stake, according to the filing. The present directors of Deru Klasik are Chryseis Tan Sheik Ling, Hew Chee Wai and Tan Cho...